Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Poon

Showing results (231-240 of 252) with videos related to

Pageof 26
Sort By:
Prostate Cancer and Prostatic Diseases|July 28, 2023
Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic reviewRossella Nicoletti, Andrea Alberti, Daniele Castellani, et al.
Bone Marrow Transplantation|January 22, 2000
Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcomeJ A Russell, L Larratt, C Brown, et al.
Oral Oncology|January 25, 2018
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)K H Au, Roger K C Ngan, Alice W Y Ng, et al.
Frontiers in Oncology|May 11, 2026
Hong Kong Urological Association-Hong Kong Society of Uro-Oncology 2025 consensus on the management of locally advanced or metastatic renal cell carcinomaDarren M C Poon, Philip W K Kwong, Samson Y S Chan, et al.
Prostate Cancer and Prostatic Diseases|July 25, 2023
Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)Rossella Nicoletti, Andrea Alberti, Daniele Castellani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2021
Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal CancerEdwin Pun Hui, Brigette B Y Ma, W K Jacky Lam, et al.
JHEP Reports : Innovation in Hepatology|April 8, 2026
Radiation-induced lymphopenia is associated with survival in patients with hepatocellular carcinoma treated with stereotactic body radiotherapyLandon L Chan, Vanessa T Y Yeung, Winnie M T Soo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2020
Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapyE P Hui, W F Li, B B Ma, et al.
Asia-Pacific Journal of Clinical Oncology|February 8, 2022
Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statementsEdmund Chiong, Declan G Murphy, Nicholas C Buchan, et al.
Asia-Pacific Journal of Clinical Oncology|March 2, 2026
Management of Advanced Prostate Cancer in the Asia-Pacific Region: Summary of the Asia-Pacific Advanced Prostate Cancer Symposium 2025Edmund Chiong, Renu Eapen, Nicholas Buchan, et al.
Pageof 26

Showing results (231-240 of 252) with videos related to

Sort By:
Pageof 26
Prostate Cancer and Prostatic Diseases|July 28, 2023
Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic reviewRossella Nicoletti, Andrea Alberti, Daniele Castellani, et al.
Bone Marrow Transplantation|January 22, 2000
Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcomeJ A Russell, L Larratt, C Brown, et al.
Oral Oncology|January 25, 2018
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)K H Au, Roger K C Ngan, Alice W Y Ng, et al.
Frontiers in Oncology|May 11, 2026
Hong Kong Urological Association-Hong Kong Society of Uro-Oncology 2025 consensus on the management of locally advanced or metastatic renal cell carcinomaDarren M C Poon, Philip W K Kwong, Samson Y S Chan, et al.
Prostate Cancer and Prostatic Diseases|July 25, 2023
Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)Rossella Nicoletti, Andrea Alberti, Daniele Castellani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2021
Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal CancerEdwin Pun Hui, Brigette B Y Ma, W K Jacky Lam, et al.
JHEP Reports : Innovation in Hepatology|April 8, 2026
Radiation-induced lymphopenia is associated with survival in patients with hepatocellular carcinoma treated with stereotactic body radiotherapyLandon L Chan, Vanessa T Y Yeung, Winnie M T Soo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2020
Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapyE P Hui, W F Li, B B Ma, et al.
Asia-Pacific Journal of Clinical Oncology|February 8, 2022
Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statementsEdmund Chiong, Declan G Murphy, Nicholas C Buchan, et al.
Asia-Pacific Journal of Clinical Oncology|March 2, 2026
Management of Advanced Prostate Cancer in the Asia-Pacific Region: Summary of the Asia-Pacific Advanced Prostate Cancer Symposium 2025Edmund Chiong, Renu Eapen, Nicholas Buchan, et al.
Pageof 26